Generated Narrative: Evidence 557357 version: 1; Last updated: 2026-04-08 13:56:39+0000 Profile: ComparatorOnlyEvidence ArtifactPublicationStatus: Active url: https://fevir.net/resources/Evidence/557357 identifier: FEvIR Object Identifier/557357, outcomeId/313960, picoId/85798, sectionId/73215 name: End_stage_kidney_disease_Comparator_Evidence_from_MAGICapp_313960 title: MAGIC-derived ComparatorOnlyEvidence: End-stage kidney disease in GLP-1 RA Group in Adults with type 2 diabetes citeAs: MAGIC-derived ComparatorOnlyEvidence: End-stage kidney disease in GLP-1 RA Group in Adults with type 2 diabetes [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 557357. Revised 2026-04-08. Available at: https://fevir.net/resources/Evidence/557357. Computable resource at: https://fevir.net/resources/Evidence/557357#json. status: Active author: Computable Publishing®: MAGIC-to-FEvIR Converter: publisher: Computable Publishing LLC contact: support@computablepublishing.com UseContexts - Code Value[x] * Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication) ComparatorOnlyEvidence copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/ RelatesTos - Type Target[x] * Part Of MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report) description: This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide. note: Defined as a GFR below 45 or a GFR below 70 AND macroalbuminuria (ACR > 200 mg/g); derived from RECODe (https://sanjaybasu.shinyapps.io/recode/). variableDefinition description: Adults with type 2 diabetes -- GLP-1 RA variableRole: Population observed: GLP-1 RA Group in Adults with type 2 diabetes variableDefinition description: End-stage kidney disease variableRole: Outcome observed: End-stage kidney disease synthesisType: NOTSET studyDesign: NO_STUDY Statistics - Description StatisticType Quantity * Risk 11.9% proportion 0.119
MAGIC-derived ComparatorOnlyEvidence: End-stage kidney disease in GLP-1 RA Group in Adults with type 2 diabetes
MAGIC-derived ComparatorOnlyEvidence: End-stage kidney disease in GLP-1 RA Group in Adults with type 2 diabetes [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 557357. Revised 2026-04-08. Available at: https://fevir.net/resources/Evidence/557357. Computable resource at: https://fevir.net/resources/Evidence/557357#json.
Computable Publishing®: MAGIC-to-FEvIR Converter
MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
Defined as a GFR below 45 or a GFR below 70 AND macroalbuminuria (ACR > 200 mg/g); derived from RECODe (https://sanjaybasu.shinyapps.io/recode/).
GLP-1 RA Group in Adults with type 2 diabetes